Page last updated: 2024-08-17

triparanol and Hypertension, Malignant

triparanol has been researched along with Hypertension, Malignant in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
HOFFMEISTER, W	1

Other Studies

1 other study(ies) available for triparanol and Hypertension, Malignant

Article	Year
[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT]. Folia clinica internacional, 1964, Volume: 14 Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extracellular Space; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Kidney Tubules; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Natriuresis; Nephrotic Syndrome; Pathology; Pharmacology; Physiology; Potassium; Sodium; Spironolactone; Toxicology; Triparanol	1964

Article

Year

[PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF SECONDARY ALDOSTERONISM AND ITS TREATMENT].

Folia clinica internacional, 1964, Volume: 14

Topics: Adrenocorticotropic Hormone; Aldosterone; Ascites; Body Fluids; Classification; Dexamethasone; Extracellular Space; Hyperaldosteronism; Hypertension; Hypertension, Malignant; Kidney Tubules; Liver Cirrhosis; Metyrapone; Mineralocorticoid Receptor Antagonists; Natriuresis; Nephrotic Syndrome; Pathology; Pharmacology; Physiology; Potassium; Sodium; Spironolactone; Toxicology; Triparanol

1964